Martin R. Pollak - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Genetics, Molecular Biology, Cell Biology

136 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ngo D, Wen D, Gao Y, Keyes MJ, Drury ER, Katz DH, Benson MD, Sinha S, Shen D, Farrell LA, Peterson BD, Friedman DJ, Elmariah S, Young BA, Smith JG, ... ... Pollak MR, et al. Circulating testican-2 is a podocyte-derived marker of kidney health. Proceedings of the National Academy of Sciences of the United States of America. PMID 32958645 DOI: 10.1073/Pnas.2009606117  0.366
2020 Datta S, Kataria R, Zhang JY, Moore S, Petitpas K, Mohamed A, Zahler N, Pollak MR, Olabisi OA. Kidney Disease-Associated Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function. Journal of the American Society of Nephrology : Jasn. PMID 32675303 DOI: 10.1681/Asn.2020010079  0.388
2020 Friedman DJ, Pollak MR. APOL1 Nephropathy: From Genetics to Clinical Applications. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 32616495 DOI: 10.2215/Cjn.15161219  0.398
2020 Feng D, Kumar M, Muntel J, Gurley SB, Birrane G, Stillman IE, Ding L, Wang M, Ahmed S, Schlondorff J, Alper SL, Ferrante T, Marquez SL, Ng CF, Novak R, ... ... Pollak MR, et al. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis. Journal of the American Society of Nephrology : Jasn. PMID 32540856 DOI: 10.1681/Asn.2019101032  0.394
2020 Chun J, Wang M, Wilkins MS, Knob AU, Benjamin A, Bu L, Pollak MR. Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease. Kidney International Reports. 5: 519-529. PMID 32274456 DOI: 10.1016/J.Ekir.2019.12.016  0.421
2020 Pollak MR, Friedman DJ. The Genetic Architecture of Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 31992573 DOI: 10.2215/Cjn.09340819  0.421
2020 Subramanian B, Chun J, Perez-Gill C, Yan P, Stillman IE, Higgs HN, Alper SL, Schlöndorff JS, Pollak MR. FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes. Journal of the American Society of Nephrology : Jasn. PMID 31924668 DOI: 10.1681/Asn.2019050443  0.349
2019 Ware EB, Smith JA, Zhao W, Ganesvoort RT, Curhan GC, Pollak M, Mount DB, Turner ST, Chen G, Shah RJ, Kardia SLR, Lieske JC. Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 3: 448-460. PMID 31993563 DOI: 10.1016/J.Mayocpiqo.2019.08.007  0.316
2019 Friedman DJ, Pollak MR. and Kidney Disease: From Genetics to Biology. Annual Review of Physiology. PMID 31710572 DOI: 10.1146/Annurev-Physiol-021119-034345  0.42
2019 Lannon H, Shah SS, Dias L, Blackler D, Alper SL, Pollak MR, Friedman DJ. Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney International. PMID 31611067 DOI: 10.1016/J.Kint.2019.07.010  0.349
2019 Drury ER, Friedman DJ, Pollak MR, Ix JH, Kuller LH, Tracy RP, Mukamal KJ. APOL1 gene variants and kidney disease in whites: the cardiovascular health study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 31580460 DOI: 10.1093/Ndt/Gfz186  0.357
2019 Shah SS, Lannon H, Dias L, Zhang JY, Alper SL, Pollak MR, Friedman DJ. APOL1 Kidney Risk Variants Induce Cell Death Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore. Journal of the American Society of Nephrology : Jasn. PMID 31558683 DOI: 10.1681/Asn.2019020114  0.359
2019 Drury ER, Stillman IE, Pollak MR, Denker BM. Autosomal Recessive Alport Syndrome Unveiled by Pregnancy. Nephron. 1-5. PMID 31408864 DOI: 10.1159/000502147  0.37
2019 Riella C, Siemens TA, Wang M, Campos RP, Moraes TP, Riella LV, Friedman DJ, Riella MC, Pollak MR. APOL1-Associated Kidney Disease in Brazil. Kidney International Reports. 4: 923-929. PMID 31317114 DOI: 10.1016/J.Ekir.2019.03.006  0.386
2019 Wang M, Chun J, Genovese G, Knob AU, Benjamin A, Wilkins MS, Friedman DJ, Appel GB, Lifton RP, Mane S, Pollak MR. Contributions of Rare Gene Variants to Familial and Sporadic FSGS. Journal of the American Society of Nephrology : Jasn. PMID 31308072 DOI: 10.1681/Asn.2019020152  0.338
2019 Chun J, Zhang JY, Wilkins MS, Subramanian B, Riella C, Magraner JM, Alper SL, Friedman DJ, Pollak MR. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity. Proceedings of the National Academy of Sciences of the United States of America. PMID 30733285 DOI: 10.1073/Pnas.1820414116  0.345
2019 Poyan Mehr A, Sadeghi-Najafabadi M, Chau K, Messmer J, Pai R, Roy N, Friedman D, Pollak MR, Schlondorff J, Naljayan M, Singh T, Lecker SH, Rodby R, Germain M, Rennke H, et al. The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and Innovation. Kidney International Reports. 4: 20-29. PMID 30596165 DOI: 10.1016/J.Ekir.2018.09.012  0.327
2018 Subramanian B, Kaya O, Pollak MR, Yao G, Zhou J. Guided tissue organization and disease modeling in a kidney tubule array. Biomaterials. 183: 295-305. PMID 30189357 DOI: 10.1016/J.Biomaterials.2018.07.059  0.351
2018 Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women. Jama Cardiology. PMID 29971324 DOI: 10.1001/Jamacardio.2018.1827  0.319
2018 Fan Y, Liu W, Bi R, Densmore MJ, Sato T, Mannstadt M, Yuan Q, Zhou X, Olauson H, Larsson TE, Toka HR, Pollak MR, Brown EM, Lanske B. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. PMID 29618612 DOI: 10.1073/Pnas.1717754115  0.335
2018 Zhang JY, Wang M, Tian L, Genovese G, Yan P, Wilson JG, Thadhani R, Mottl AK, Appel GB, Bick AG, Sampson MG, Alper SL, Friedman DJ, Pollak MR. modifies-induced kidney disease risk. Proceedings of the National Academy of Sciences of the United States of America. PMID 29531077 DOI: 10.1073/Pnas.1716113115  0.399
2018 Feng D, Notbohm J, Benjamin A, He S, Wang M, Ang LH, Bantawa M, Bouzid M, Del Gado E, Krishnan R, Pollak MR. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch. Proceedings of the National Academy of Sciences of the United States of America. PMID 29378953 DOI: 10.1073/Pnas.1717870115  0.336
2018 Feng D, DuMontier C, Pollak MR. The mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis. American Journal of Physiology. Renal Physiology. PMID 29363327 DOI: 10.1152/Ajprenal.00641.2017  0.33
2017 Pollak MR. Introduction: APOL1-Associated Kidney Disease. Seminars in Nephrology. 37: 489. PMID 29110755 DOI: 10.1016/J.Semnephrol.2017.07.001  0.373
2017 Wang H, Pun PH, Kwee L, Craig D, Haynes C, Chryst-Ladd M, Svetkey LP, Patel UD, Hauser ER, Pollak MR, Kraus WE, Shah SH. Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization. Cardiorenal Medicine. 7: 96-103. PMID 28611783 DOI: 10.1159/000453458  0.379
2017 Sato T, Courbebaisse M, Ide N, Fan Y, Hanai JI, Kaludjerovic J, Densmore MJ, Yuan Q, Toka HR, Pollak MR, Hou J, Lanske B. Parathyroid hormone controls paracellular Ca(2+) transport in the thick ascending limb by regulating the tight-junction protein Claudin14. Proceedings of the National Academy of Sciences of the United States of America. PMID 28373577 DOI: 10.1073/Pnas.1616733114  0.327
2017 Skorecki KL, Lee JH, Langefeld CD, Rosset S, Tzur S, Wasser WG, Shemer R, Hawkins GA, Divers J, Parekh RS, Li M, Sampson MG, Kretzler M, Pollak MR, Shah S, et al. A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 28339911 DOI: 10.1093/Ndt/Gfw451  0.343
2016 Greka A, Gibson D, Mundel P, Demetri G, Hildebrandt F, Pollak M, Florez J. Personalized Comments on Challenges and Opportunities in Kidney Disease Therapeutics: The Glom-NExT Symposium. Seminars in Nephrology. 36: 448. PMID 27987543 DOI: 10.1016/J.Semnephrol.2016.09.005  0.345
2016 Feng D, Steinke JM, Krishnan R, Birrane G, Pollak MR. Functional Validation of an Alpha-Actinin-4 Mutation as a Potential Cause of an Aggressive Presentation of Adolescent Focal Segmental Glomerulosclerosis: Implications for Genetic Testing. Plos One. 11: e0167467. PMID 27977723 DOI: 10.1371/Journal.Pone.0167467  0.427
2016 Olabisi O, Al-Romaih K, Henderson J, Tomar R, Drummond I, MacRae C, Pollak M. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy? Clinical Nephrology. PMID 27509583 DOI: 10.5414/Cnp86S116  0.32
2016 Subramanian B, Sun H, Yan P, Charoonratana VT, Higgs HN, Wang F, Lai KV, Valenzuela DM, Brown EJ, Schlöndorff JS, Pollak MR. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury. Kidney International. PMID 27350175 DOI: 10.1016/J.Kint.2016.04.020  0.382
2016 Bondzie PA, Chen HA, Cao MZ, Tomolonis JA, He F, Pollak MR, Henderson JM. Non-muscle Myosin-IIA is Critical for Podocyte F-actin Organization, Contractility and Attenuation of Cell Motility. Cytoskeleton (Hoboken, N.J.). PMID 27232264 DOI: 10.1002/Cm.21313  0.308
2016 Friedman DJ, Pollak MR. Apolipoprotein L1 and Kidney Disease in African Americans. Trends in Endocrinology and Metabolism: Tem. PMID 26947522 DOI: 10.1016/J.Tem.2016.02.002  0.411
2016 Sharma AK, Friedman DJ, Pollak MR, Alper SL. Structural characterization of the C-terminal coiled coil domains of wild-type and kidney disease associated mutants of Apolipoprotein L1. The Febs Journal. PMID 26945671 DOI: 10.1111/Febs.13706  0.32
2015 Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proceedings of the National Academy of Sciences of the United States of America. PMID 26699492 DOI: 10.1073/Pnas.1522913113  0.331
2015 Mukamal KJ, Tremaglio J, Friedman DJ, Ix JH, Kuller LH, Tracy RP, Pollak MR. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26634651 DOI: 10.1161/Atvbaha.115.305970  0.356
2015 MacRae CA, Pollak MR. Effect Size Does Matter: The Long Road to Mechanistic Insight From Genome Wide Association. Circulation. PMID 26487758 DOI: 10.1161/Circulationaha.115.019306  0.336
2015 Feng D, DuMontier C, Pollak MR. The role of alpha-actinin-4 in human kidney disease. Cell & Bioscience. 5: 44. PMID 26301083 DOI: 10.1186/S13578-015-0036-8  0.446
2015 Sampson MG, Pollak MR. Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era. Seminars in Nephrology. 35: 212-21. PMID 26215859 DOI: 10.1016/J.Semnephrol.2015.04.002  0.344
2015 Toka HR, Pollak MR, Houillier P. Calcium Sensing in the Renal Tubule. Physiology (Bethesda, Md.). 30: 317-26. PMID 26136545 DOI: 10.1152/Physiol.00042.2014  0.321
2015 Pollak MR. Modifiers of Cardiac Phenotypes. Circulation. Cardiovascular Genetics. 8: 425-6. PMID 26082553 DOI: 10.1161/Circgenetics.115.001122  0.358
2015 Ruchi R, Genovese G, Lee J, Charoonratana VT, Bernhardy AJ, Alper SL, Kopp JB, Thadhani R, Friedman DJ, Pollak MR. Copy Number Variation at the APOL1 Locus. Plos One. 10: e0125410. PMID 25933006 DOI: 10.1371/Journal.Pone.0125410  0.403
2015 Pollak MR. Idiopathic pediatric chronic kidney disease: can genomic technology crack the case? The Journal of Clinical Investigation. 125: 1799-800. PMID 25893596 DOI: 10.1172/Jci81509  0.307
2015 Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D'Agati VD, Nast CC, Wei C, Reiser J, Guay-Woodford LM, Pollak MR, Hildebrandt F, Moxey-Mims M, Gipson DS, Trachtman H, et al. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. Journal of the American Society of Nephrology : Jasn. 26: 1443-8. PMID 25573908 DOI: 10.1681/Asn.2013111242  0.335
2015 Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D'Agati V, Markowitz G, Kopp JB, Alper SL, Pollak MR, Friedman DJ. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney International. 87: 332-42. PMID 25100047 DOI: 10.1038/Ki.2014.270  0.354
2015 Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, Saleem MA, Satchell SC, Banas B, Mathieson PW, Kretzler M, Hemal AK, Rudel LL, Petrovic S, Weckerle A, ... Pollak MR, et al. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. Journal of the American Society of Nephrology : Jasn. 26: 339-48. PMID 25012173 DOI: 10.1681/Asn.2013091017  0.321
2014 Sun H, Al-Romaih KI, MacRae CA, Pollak MR. Human Kidney Disease-causing INF2 Mutations Perturb Rho/Dia Signaling in the Glomerulus. Ebiomedicine. 1: 107-15. PMID 26086034 DOI: 10.1016/J.Ebiom.2014.11.009  0.402
2014 Toka HR, Pollak MR. The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease. Current Opinion in Nephrology and Hypertension. 23: 494-501. PMID 24992569 DOI: 10.1097/Mnh.0000000000000042  0.309
2014 Grgic I, Hofmeister AF, Genovese G, Bernhardy AJ, Sun H, Maarouf OH, Bijol V, Pollak MR, Humphreys BD. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney International. 86: 1116-29. PMID 24940801 DOI: 10.1038/Ki.2014.204  0.326
2014 Thomson R, Genovese G, Canon C, Kovacsics D, Higgins MK, Carrington M, Winkler CA, Kopp J, Rotimi C, Adeyemo A, Doumatey A, Ayodo G, Alper SL, Pollak MR, Friedman DJ, et al. Evolution of the primate trypanolytic factor APOL1. Proceedings of the National Academy of Sciences of the United States of America. 111: E2130-9. PMID 24808134 DOI: 10.1073/Pnas.1400699111  0.375
2014 Gbadegesin RA, Hall G, Adeyemo A, Hanke N, Tossidou I, Burchette J, Wu G, Homstad A, Sparks MA, Gomez J, Jiang R, Alonso A, Lavin P, Conlon P, Korstanje R, ... ... Pollak MR, et al. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. Journal of the American Society of Nephrology : Jasn. 25: 1991-2002. PMID 24676636 DOI: 10.1681/Asn.2013090976  0.437
2014 Barua M, Stellacci E, Stella L, Weins A, Genovese G, Muto V, Caputo V, Toka HR, Charoonratana VT, Tartaglia M, Pollak MR. Mutations in PAX2 associate with adult-onset FSGS. Journal of the American Society of Nephrology : Jasn. 25: 1942-53. PMID 24676634 DOI: 10.1681/Asn.2013070686  0.405
2014 Brown EJ, Pollak MR, Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney International. 85: 1030-8. PMID 24599252 DOI: 10.1038/Ki.2014.48  0.311
2014 Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, Depalma SR, Gupta N, Gabriel SB, Taylor HA, Fox ER, Newton-Cheh C, Kathiresan S, Hirschhorn JN, Altshuler DM, ... Pollak MR, et al. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circulation Research. 114: 845-50. PMID 24379297 DOI: 10.1161/Circresaha.114.302347  0.351
2014 Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC. Plasma apolipoprotein L1 levels do not correlate with CKD. Journal of the American Society of Nephrology : Jasn. 25: 634-44. PMID 24231663 DOI: 10.1681/Asn.2013070700  0.341
2014 Barua M, Shieh E, Schlondorff J, Genovese G, Kaplan BS, Pollak MR. Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis. Kidney International. 85: 124-33. PMID 24048372 DOI: 10.1038/Ki.2013.354  0.412
2013 Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, ... ... Pollak M, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. The Journal of Clinical Investigation. 123: 5179-89. PMID 24270420 DOI: 10.1172/Jci69000  0.368
2013 Williams WW, Pollak MR. Health disparities in kidney disease - Emerging data from the human genome New England Journal of Medicine. 369: 2260-2261. PMID 24206461 DOI: 10.1056/Nejme1312797  0.347
2013 Toka HR, Genovese G, Mount DB, Pollak MR, Curhan GC. Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. Plos One. 8: e71885. PMID 23991001 DOI: 10.1371/Journal.Pone.0071885  0.334
2013 Toka HR, Yang J, Zera CA, Duffield JS, Pollak MR, Mount DB. Pregnancy-associated polyuria in familial renal glycosuria. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 1160-4. PMID 23871407 DOI: 10.1053/J.Ajkd.2013.05.018  0.345
2013 Sun H, Schlondorff J, Higgs HN, Pollak MR. Inverted formin 2 regulates actin dynamics by antagonizing Rho/diaphanous-related formin signaling. Journal of the American Society of Nephrology : Jasn. 24: 917-29. PMID 23620398 DOI: 10.1681/Asn.2012080834  0.305
2013 Romero JR, Youte R, Brown EM, Pollak MR, Goltzman D, Karaplis A, Pong LC, Chien L, Chattopadhyay N, Rivera A. Parathyroid hormone ablation alters erythrocyte parameters that are rescued by calcium-sensing receptor gene deletion European Journal of Haematology. 91: 37-45. PMID 23528155 DOI: 10.1111/Ejh.12110  0.309
2013 Genovese G, Friedman DJ, Pollak MR. APOL1 variants and kidney disease in people of recent African ancestry. Nature Reviews. Nephrology. 9: 240-4. PMID 23438974 DOI: 10.1038/Nrneph.2013.34  0.428
2013 Kirby A, Gnirke A, Jaffe DB, Barešová V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, ... ... Pollak MR, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nature Genetics. 45: 299-303. PMID 23396133 DOI: 10.1038/Ng.2543  0.347
2013 Barua M, Brown EJ, Charoonratana VT, Genovese G, Sun H, Pollak MR. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney International. 83: 316-22. PMID 23014460 DOI: 10.1038/Ki.2012.349  0.399
2012 Toka HR, Al-Romaih K, Koshy JM, DiBartolo S, Kos CH, Quinn SJ, Curhan GC, Mount DB, Brown EM, Pollak MR. Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. Journal of the American Society of Nephrology : Jasn. 23: 1879-90. PMID 22997254 DOI: 10.1681/Asn.2012030323  0.354
2012 Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival American Journal of Transplantation. 12: 1924-1928. PMID 22487534 DOI: 10.1111/J.1600-6143.2012.04033.X  0.342
2012 Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Current Opinion in Nephrology and Hypertension. 21: 179-82. PMID 22257798 DOI: 10.1097/Mnh.0B013E32835012Ab  0.399
2012 Boucher I, Yu W, Beaudry S, Negoro H, Tran M, Pollak MR, Henderson JM, Denker BM. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 662-75. PMID 22249312 DOI: 10.1038/Labinvest.2011.198  0.357
2011 Kanji Z, Powe CE, Wenger JB, Huang C, Ankers E, Sullivan DA, Collerone G, Powe NR, Tonelli M, Bhan I, Bernhardy AJ, Dibartolo S, Friedman D, Genovese G, Pollak MR, et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. Journal of the American Society of Nephrology : Jasn. 22: 2091-7. PMID 21997398 DOI: 10.1681/Asn.2010121234  0.348
2011 Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR. Population-based risk assessment of APOL1 on renal disease. Journal of the American Society of Nephrology : Jasn. 22: 2098-105. PMID 21997396 DOI: 10.1681/Asn.2011050519  0.331
2011 Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, ... ... Pollak M, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. Journal of the American Society of Nephrology : Jasn. 22: 2129-37. PMID 21997394 DOI: 10.1681/Asn.2011040388  0.355
2011 Akilesh S, Suleiman H, Yu H, Stander MC, Lavin P, Gbadegesin R, Antignac C, Pollak M, Kopp JB, Winn MP, Shaw AS. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. The Journal of Clinical Investigation. 121: 4127-37. PMID 21911940 DOI: 10.1172/Jci46458  0.406
2011 Friedman DJ, Pollak MR. Genetics of kidney failure and the evolving story of APOL1 Journal of Clinical Investigation. 121: 3367-3374. PMID 21881214 DOI: 10.1172/Jci46263  0.415
2011 Shankland SJ, Pollak MR. A suPAR circulating factor causes kidney disease. Nature Medicine. 17: 926-7. PMID 21818086 DOI: 10.1038/Nm.2443  0.375
2011 Yao NY, Becker DJ, Broedersz CP, Depken M, Mackintosh FC, Pollak MR, Weitz DA. Nonlinear viscoelasticity of actin transiently cross-linked with mutant α-actinin-4. Journal of Molecular Biology. 411: 1062-71. PMID 21762701 DOI: 10.1016/J.Jmb.2011.06.049  0.314
2011 Al-Romaih KI, Genovese G, Al-Mojalli H, Al-Othman S, Al-Manea H, Al-Suleiman M, Al-Jondubi M, Atallah N, Al-Rodayyan M, Weins A, Pollak MR, Adra CN. Genetic diagnosis in consanguineous families with kidney disease by homozygosity mapping coupled with whole-exome sequencing. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 58: 186-95. PMID 21658830 DOI: 10.1053/J.Ajkd.2011.01.025  0.396
2011 Liakopoulos V, Huerta A, Cohen S, Pollak MR, Sirota RA, Superdock K, Appel GB. Familial collapsing focal segmental glomerulosclerosis Clinical Nephrology. 75: 362-368. PMID 21426891 DOI: 10.5414/Cn106544  0.32
2011 Sun H, Schlondorff JS, Brown EJ, Higgs HN, Pollak MR. Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2). Proceedings of the National Academy of Sciences of the United States of America. 108: 2933-8. PMID 21278336 DOI: 10.1073/Pnas.1017010108  0.381
2011 Wyss HM, Henderson JM, Byfield FJ, Bruggeman LA, Ding Y, Huang C, Suh JH, Franke T, Mele E, Pollak MR, Miner JH, Janmey PA, Weitz DA, Miller RT. Biophysical properties of normal and diseased renal glomeruli. American Journal of Physiology. Cell Physiology. 300: C397-405. PMID 21123730 DOI: 10.1152/Ajpcell.00438.2010  0.383
2011 Pollak M. Biological Mechanisms of Focal Glomerulosclerosis: A Major Cause of Acquired and Inherited Renal Disease Annual Review of Medicine. 63: 110301100719093. DOI: 10.1146/Annurev.Med.041608.121355  0.382
2010 Pollak MR. Genetics and genetic testing in kidney disease: introduction. Seminars in Nephrology. 30: 355. PMID 20807607 DOI: 10.1016/J.Semnephrol.2010.06.001  0.357
2010 Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. Journal of the American Society of Nephrology : Jasn. 21: 1422-6. PMID 20688934 DOI: 10.1681/Asn.2010070730  0.377
2010 Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney International. 78: 698-704. PMID 20668430 DOI: 10.1038/Ki.2010.251  0.385
2010 Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, ... ... Pollak MR, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (New York, N.Y.). 329: 841-5. PMID 20647424 DOI: 10.1126/Science.1193032  0.375
2010 Grünfeld JP, Hwu W, Chien Y, Lee N, Chiang S, Dobrovolny R, Huang A, Yeh H, Chao M, Lin S, Kitagawa T, Desnick R, Hsu L, Van Keimpema L, Nevens F, ... ... Pollak M, et al. More on clinical renal genetics. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 563-7. PMID 20338964 DOI: 10.2215/Cjn.01720210  0.371
2010 Brown EJ, Schlöndorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, Higgs HN, Henderson JM, Pollak MR. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nature Genetics. 42: 72-6. PMID 20023659 DOI: 10.1038/Ng.505  0.393
2009 Pollak MR. Expanding the spectrum of NPHS1-associated disease. Kidney International. 76: 1221-3. PMID 19946311 DOI: 10.1038/Ki.2009.391  0.363
2009 Pollak MR. Surprising results following conditional podocyte inactivation. Journal of the American Society of Nephrology : Jasn. 20: 2086-8. PMID 19762489 DOI: 10.1681/Asn.2009080854  0.357
2009 Egbuna O, Quinn S, Kantham L, Butters R, Pang J, Pollak M, Goltzman D, Brown E. The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone. American Journal of Physiology. Renal Physiology. 297: F720-8. PMID 19474191 DOI: 10.1152/Ajprenal.00164.2009  0.307
2009 Henderson JM, Alexander MP, Pollak MR. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury. Journal of the American Society of Nephrology : Jasn. 20: 961-8. PMID 19357256 DOI: 10.1681/Asn.2008060613  0.386
2009 Schlöndorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. American Journal of Physiology. Cell Physiology. 296: C558-69. PMID 19129465 DOI: 10.1152/Ajpcell.00077.2008  0.325
2008 Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR. NPHS2 variation in focal and segmental glomerulosclerosis. Bmc Nephrology. 9: 13. PMID 18823551 DOI: 10.1186/1471-2369-9-13  0.332
2008 Pollak MR. Kidney disease and African ancestry. Nature Genetics. 40: 1145-6. PMID 18818713 DOI: 10.1038/Ng1008-1145  0.369
2008 Ward SM, Weins A, Pollak MR, Weitz DA. Dynamic viscoelasticity of actin cross-linked with wild-type and disease-causing mutant alpha-actinin-4. Biophysical Journal. 95: 4915-23. PMID 18689451 DOI: 10.1529/Biophysj.108.131722  0.317
2008 Leibon G, Rockmore DN, Pollak MR. A SNP streak model for the identification of genetic regions identical-by-descent. Statistical Applications in Genetics and Molecular Biology. 7: Article16. PMID 18518857 DOI: 10.2202/1544-6115.1340  0.321
2008 Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, ... ... Pollak MR, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proceedings of the National Academy of Sciences of the United States of America. 105: 6998-7003. PMID 18458324 DOI: 10.1073/Pnas.0800454105  0.326
2008 Pollak MR. Focal segmental glomerulosclerosis: recent advances. Current Opinion in Nephrology and Hypertension. 17: 138-42. PMID 18277145 DOI: 10.1097/Mnh.0B013E3282F5Dbe4  0.315
2008 Tonna S, Dandapani SV, Uscinski A, Appel GB, Schlöndorff JS, Zhang K, Denker BM, Pollak MR. Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS). Gene. 410: 44-52. PMID 18206321 DOI: 10.1016/J.Gene.2007.11.014  0.72
2008 Henderson JM, Al-Waheeb S, Weins A, Dandapani SV, Pollak MR. Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease. Kidney International. 73: 741-50. PMID 18185509 DOI: 10.1038/Sj.Ki.5002751  0.696
2007 Mistry K, Ireland JH, Ng RC, Henderson JM, Pollak MR. Novel mutations in NPHP4 in a consanguineous family with histological findings of focal segmental glomerulosclerosis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 855-64. PMID 17954299 DOI: 10.1053/J.Ajkd.2007.08.009  0.431
2007 Pollak MR, Alexander MP, Henderson JM. A case of familial kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 1367-74. PMID 17942774 DOI: 10.2215/Cjn.02040507  0.356
2007 Weins A, Schlondorff JS, Nakamura F, Denker BM, Hartwig JH, Stossel TP, Pollak MR. Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proceedings of the National Academy of Sciences of the United States of America. 104: 16080-5. PMID 17901210 DOI: 10.1073/Pnas.0702451104  0.31
2007 Copelovitch L, Guttenberg M, Pollak MR, Kaplan BS. Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS. Pediatric Nephrology (Berlin, Germany). 22: 1779-84. PMID 17530296 DOI: 10.1007/S00467-007-0505-3  0.385
2007 Dandapani SV, Sugimoto H, Matthews BD, Kolb RJ, Sinha S, Gerszten RE, Zhou J, Ingber DE, Kalluri R, Pollak MR. Alpha-actinin-4 is required for normal podocyte adhesion. The Journal of Biological Chemistry. 282: 467-77. PMID 17082197 DOI: 10.1074/Jbc.M605024200  0.674
2006 Schlöndorff JS, Pollak MR. TRPC6 in glomerular health and disease: what we know and what we believe. Seminars in Cell & Developmental Biology. 17: 667-74. PMID 17116414 DOI: 10.1016/J.Semcdb.2006.11.003  0.415
2006 Dandapani SV, Pollak MR. The glomerular filter: Biologic and genetic complexity. Kidney International. 70: 980-2. PMID 16957744 DOI: 10.1038/Sj.Ki.5001801  0.701
2006 Möller CC, Pollak MR, Reiser J. The genetic basis of human glomerular disease. Advances in Chronic Kidney Disease. 13: 166-73. PMID 16580618 DOI: 10.1053/J.Ackd.2006.01.009  0.417
2005 Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, Appel GB, Pollak MR. Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. Journal of the American Society of Nephrology : Jasn. 16: 3694-701. PMID 16251236 DOI: 10.1681/Asn.2005070706  0.404
2005 Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, ... ... Pollak MR, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nature Genetics. 37: 739-44. PMID 15924139 DOI: 10.1038/Ng1592  0.41
2004 Ellinor PT, Moore RK, Patton KK, Ruskin JN, Pollak MR, Macrae CA. Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart (British Cardiac Society). 90: 1487-8. PMID 15547041 DOI: 10.1136/Hrt.2003.027227  0.351
2004 Yao J, Le TC, Kos CH, Henderson JM, Allen PG, Denker BM, Pollak MR. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. Plos Biology. 2: e167. PMID 15208719 DOI: 10.1371/Journal.Pbio.0020167  0.402
2004 Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR, Mill JG, Krieger JE. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney International. 65: 1026-30. PMID 14871423 DOI: 10.1111/J.1523-1755.2004.00479.X  0.389
2003 Kos CH, Le TC, Sinha S, Henderson JM, Kim SH, Sugimoto H, Kalluri R, Gerszten RE, Pollak MR. Mice deficient in alpha-actinin-4 have severe glomerular disease. The Journal of Clinical Investigation. 111: 1683-90. PMID 12782671 DOI: 10.1172/Jci17988  0.35
2003 Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis. Seminars in Nephrology. 23: 141-6. PMID 12704574 DOI: 10.1053/Snep.2003.50014  0.402
2003 Kos CH, Karaplis AC, Peng JB, Hediger MA, Goltzman D, Mohammad KS, Guise TA, Pollak MR. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. The Journal of Clinical Investigation. 111: 1021-8. PMID 12671051 DOI: 10.1172/Jci17416  0.357
2002 Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. The Journal of Clinical Investigation. 110: 1659-66. PMID 12464671 DOI: 10.1172/Jci16242  0.379
2002 Pollak MR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. Journal of the American Society of Nephrology : Jasn. 13: 3016-23. PMID 12444222 DOI: 10.1097/01.Asn.0000039569.34360.5E  0.368
2001 Kaplan J, Pollak MR. Familial focal segmental glomerulosclerosis Current Opinion in Nephrology and Hypertension. 10: 183-187. PMID 11224692 DOI: 10.1097/00041552-200103000-00005  0.332
2000 Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodríguez-Pérez JC, Allen PG, Beggs AH, Pollak MR. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genetics. 24: 251-6. PMID 10700177 DOI: 10.1038/73456  0.431
1998 Brown EM, Pollak M, Hebert SC. The extracellular calcium-sensing receptor: Its role in health and disease Annual Review of Medicine. 49: 15-29. PMID 9509247 DOI: 10.1146/Annurev.Med.49.1.15  0.349
1998 Mathis BJ, Kim SH, Calabrese K, Haas M, Seidman JG, Seidman CE, Pollak MR. A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13: Rapid communication Kidney International. 53: 282-286. PMID 9461087 DOI: 10.1046/J.1523-1755.1998.00828.X  0.326
1996 Pollak MR, Seidman CE, Brown EM. Three inherited disorders of calcium sensing Medicine. 75: 115-123. PMID 8965680 DOI: 10.1097/00005792-199605000-00001  0.361
1996 Károlyi L, Ziegler A, Pollak M, Fischbach M, Grzeschik K, Koch MC, Seyberth HW. Gitelman’s syndrome is genetically distinct from other forms of Bartter’s syndrome Pediatric Nephrology. 10: 551-554. PMID 8897553 DOI: 10.1007/S004670050158  0.312
1996 Bai M, Quinn S, Trivedi S, Kifor O, Pearce SHS, Pollak MR, Krapcho K, Hebert SC, Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+(o)-sensing receptor Journal of Biological Chemistry. 271: 19537-19545. PMID 8702647 DOI: 10.1074/Jbc.271.32.19537  0.346
1995 Brown EM, Pollak M, Chou YH, Seidman CE, Seidman JG, Hebert SC. Cloning and functional characterization of extracellular Ca2+-sensing receptors from parathyroid and kidney Bone. 17. PMID 8579901 DOI: 10.1016/8756-3282(95)00199-N  0.315
1995 Brown EM, Pollak M, Hebert SC. Sensing of extracellular Ca2+ by parathyroid and kidney cells: Cloning and characterization of an extracellular Ca2+-sensing receptor American Journal of Kidney Diseases. 25: 506-513. PMID 7872334 DOI: 10.1016/0272-6386(95)90118-3  0.323
1995 Brown EM, Pollak M, Hebert SC. Molecular mechanisms underlying the sensing of extracellular Ca2+ by parathyroid and kidney cells European Journal of Endocrinology. 132: 523-531. PMID 7749489 DOI: 10.1530/Eje.0.1320523  0.325
1995 Brown EM, Pollak M, Chou YHW, Seidman CE, Seidman JG, Hebert SC. The cloning of extracellular Ca2+-sensing receptors from parathyroid and kidney: Molecular mechanisms of extracellular Ca2+-sensing Journal of Nutrition. 125. PMID 7602378 DOI: 10.1093/Jn/125.Suppl_7.1965S  0.304
1995 Hosokawa Y, Pollak MR, Brown EM, Arnold A. Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors Journal of Clinical Endocrinology and Metabolism. 80: 3107-3110. PMID 7593409 DOI: 10.1210/Jcem.80.11.7593409  0.342
1995 Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Nature Genetics. 11: 389-394. PMID 7493018 DOI: 10.1038/Ng1295-389  0.355
1995 Pollak MR, Chou YW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Pediatric Nephrology. 9: 297-297. DOI: 10.1016/B978-0-12-397166-1.00024-2  0.364
1994 Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: Effects of mutant gene dosage on phenotype Journal of Clinical Investigation. 93: 1108-1112. PMID 8132750 DOI: 10.1007/Bf02254188  0.313
1994 Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG. Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation Nature Genetics. 8: 303-307. PMID 7874174 DOI: 10.1038/Ng1194-303  0.336
1994 Brown EM, Pollak M, Riccardi D, Hebert SC. Cloning and characterization of an extracellular Ca2+ -sensing receptor from parathyroid and kidney: new insights into the physiology and pathophysiology of calcium metabolism Nephrology Dialysis Transplantation. 9: 1703-1706. DOI: 10.1093/Ndt/9.12.1703  0.302
1993 Pollak MR, Brown EM, Chou YHW, Hebert SC, Marx SJ, Stelnmann B, Levi T, Seidman CE, Seidman JG. Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Cell. 75: 1297-1303. PMID 7916660 DOI: 10.1016/0092-8674(93)90617-Y  0.334
Show low-probability matches.